Mira Pharmaceuticals Announces Positive Preclinical Study Results For Its Novel Oral ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This Year
Stock Information for MIRA Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.